We recently compiled a list of the 10 Best Investments During A Recession. The Cigna Group stands sixth on our list among the best investments.
TheFly reported on January 9 that Mizuho analyst Ann Hynes maintained a Buy rating on CI and adjusted the price target to $325 from $307. The firm noted that its physician survey shows healthcare utilization growth is slowing sequentially, suggesting the trend may be peaking.
Separately, on January 13, 2026, The Cigna Group officially announced that it will release its fourth quarter 2025 financial results on Thursday, February 5, 2026.
The Cigna Group (NYSE:CI) is a global health services company providing medical, dental, behavioral health, pharmacy, and supplemental insurance solutions. It operates in over 30 countries, serving individuals, employers, and governments, with a growing focus on integrated care, pharmacy benefit management, and international health markets.
While we acknowledge the potential of CI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Best Multibagger Stocks to Buy Heading into 2026 and 7 Best Rising Tech Stocks to Buy Now.
Disclosure: None.
